Brief: Synlogic Announces Synb1353 Achieves Proof Of Mechanism For Treatment Of Homocystinuria And Provides Business Update
30/11/2022 21:40
Nov 30 (Reuters) - Synlogic Inc SYBX.O :
* SYNLOGIC ANNOUNCES SYNB1353 ACHIEVES PROOF OF MECHANISM
FOR
TREATMENT OF HOMOCYSTINURIA AND PROVIDES BUSINESS UPDATE
Source text for Eikon: ID:nGNX3l4WN2
Further company coverage: SYBX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Synlogic
See all newsBrief: Synlogic Receives Letter From Nasdaq Listing Qualifications Department On Nov 21 - SEC Filing
Brief: Synlogic Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing
Synlogic Inc reports results for the quarter ended September 30 - Earnings Summary
Synlogic Inc expected to post a loss of 10 cents a share - Earnings Preview
Synlogic Inc reports results for the quarter ended in January - Earnings Summary